Gonococcal/Chlamydia trachomatis/ureaplasma urealyticum infection
Conditions
Interventions
Gold Standard:Second generation sequencing (NGS), NG, CT, UU nucleic acid detection reagents
Index test:Method for detecting NG, CT, and UU nucleic acids using fluorescence quantitative PCR technology
Sponsors
Beijing Ditan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years old; 2. Sexual life history; 3. Suspected NG, CT, UU infection (including but not limited to the occurrence of related symptoms, high-risk sexual behavior, health examination, etc.), and voluntarily accept relevant tests; 4. "Disease group" : subjects infected with one or more NG, CT, UU; 5. "Control group" : subjects did not have NG, CT, UU infection; 6. Volunteer to participate in this study and sign the informed consent after communication.
Exclusion criteria
Exclusion criteria: 1. Clinical manifestations were limited to the non-urogenital system such as eyes, pharynx, anus and rectum; 2. Received local or systemic anti-infection treatment in the past 21 days; 3. Received urethral or reproductive tract irrigation in the last 24 hours; 4. Known pregnant or lactating women; 5. Unable to complete sample collection; 6. Refusal or inability to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity; | — |
Countries
China
Contacts
Public ContactYajie Wang
Beijing Ditan Hospital, Capital Medical University
Outcome results
None listed